NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.
Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.
An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
The CHIPS for America funding opportunity will support critical research, prototyping and commercial solutions that advance microelectronics technology in the
The NIST reference material, called NISTCHO, will help the biopharmaceutical industry develop new drugs more quickly and ensure that they are safe and effective
The technology, which may someday be as portable as a smartphone, promises faster and more accurate measurements of radiation exposure, potentially saving lives
Using detailed simulations, researchers at the National Institute of Standards and Technology (NIST) and their collaborators have demonstrated that a class of
The winning projects were competitively selected following a call for innovative proposals that address technical needs related to NIST’s research areas.
The Centers for Disease Control and Prevention (CDC) estimates that over 40 % of Americans suffer from diabetes-related conditions, including 29 million
NIST received requests from scientists in the biopharmaceutical industry, instrument vendors, and from the U.S. Food and Drug Administration to develop a
Messenger RNA ( mRNA)-based therapies require a careful assessment of Critical Quality Attributes (CQAs) using various analytical techniques, to ensure
As NIST’s National Construction Safety Team nears the end of its investigation, it has released a video update that highlights significant milestones and
After the release of NISTmAb RM 8671, the biopharmaceutical community noted that a monoclonal antibody (mAb) producing Chinese hamster ovary line (CHO) cell
NIST recently hosted a training course for graduate students and early-career researchers at its lab in Gaithersburg, Maryland. The participants learned about
NIST researcher Dr. Edward Griffor co-organized the London Healthcare Innovation Forum on April 3, 2025 at London’s Canary Wharf in the United Kingdom. With
This reference material is intended to be used as quality assurance/quality control material for laboratory metabolomic measurements. Products of metabolism act
Electrolytes are essential biomarkers for skeletal and cellular health. Abnormal levels of electrolytes may either be the cause or the consequence of various
To bolster the nation’s preparedness for a pandemic, the National Institute of Standards and Technology (NIST) has developed a synthetic, nonhazardous genetic